Key result
Oscillatory rheometer matches ball coagulometer for clotting times and differentiates heparin and protamine concentrations.
Why the study?
No single medical device is currently available to provide a comprehensive solution for monitoring coagulation status including coagulation, platelets, and fibrinolysis during open heart surgery.
Does an oscillatory rheometer accurately measure blood coagulation status compared to a ball coagulometer in citrated blood samples?
Does an oscillatory rheometer accurately measure blood coagulation status compared to a ball coagulometer in citrated blood samples?
An oscillatory rheometer can dynamically and quantitatively assess blood coagulation status, including heparin and protamine effects, comparable to standard coagulometers.
Oscillatory rheometry matches ball coagulometry in animal models; leaves open human validation for heparin monitoring.
During open heart surgery, the haemostasis status of a patient has to be monitored permanently in order to quickly and reliably detect bleeding or coagulation-based disorders. Currently, no single medical device is available to provide a comprehensive solution for monitoring the coagulation status (coagulation, platelets and fibrinolysis). We intend to approach this problem with a rheological method. Here, we compared the performance of an oscillatory rheometer with a medical reference device, a ball coagulometer. Measuring the extrinsic coagulation (prothrombin time; PT), various heparin concentrations (0.5–2.0 IU/mL) could be differentiated and also discriminated from the intrinsic coagulation (activated partial thromboplastin time; aPTT) providing comparable clotting times between rheometer and ball coagulometer. In addition, the oscillatory rheometer was capable to detect the antagonising of heparin with the equimolar concentration of protamine and also the titration of various protamine concentrations (0.5–3.0 IU/mL) to a fixed heparin concentration (2 IU/mL). The addition of increasing concentrations of heparin to citrated blood prolonged the clotting time (CT), changed the slope calculated by linear regression of the elastic and viscous shear moduli (i.e., information of the coagulation process) and changed the value of the shear moduli at the end of the measurement (300 s). These results indicate that the oscillatory rheometer is capable to dynamically measure the haemostasis status with different activators and various inhibitor concentrations.
No takes yet. Share an insight, caveat, or question.
Kunnakattu et al. (2018) studied Blood coagulation status monitoring. Oscillatory rheometer vs. Ball coagulometer was evaluated on Clotting times and differentiation of heparin and protamine concentrations. An oscillatory rheometer provided comparable clotting times to a ball coagulometer and successfully differentiated various heparin (0.5-2.0 IU/mL) and protamine concentrations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: